Actively Recruiting
Studying Venous Excess Ultrasound and Lung Ultrasound Scores to Understand Kidney Injury and Death in ICU Patients
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-09-05
136
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating the relationship between the venous excess ultrasound grading system VExUS and important health outcomes in patients admitted to the intensive care unit ICU. The study focuses on how VExUS relates to acute kidney injury, mortality, and length of hospital stay. Additionally, the connection between VExUS and lung ultrasound scores will be explored as a secondary analysis to better understand fluid overload risks in ICU patients. The study is observational and involves monitoring patients admitted to the ICU who are 18 years or older and expected to stay more than 24 hours. There are no experimental treatments in this study instead, ultrasound assessments including VExUS and lung ultrasound scores will be performed to gather data. These ultrasound techniques are used to evaluate how the body handles fluids and to identify patients at risk of fluid overload. Participants will undergo ultrasound assessments and their health outcomes will be tracked for up to 30 days after ICU admission. Researchers will collect data on acute kidney injury rates, mortality, and major adverse kidney events within this period. No experimental interventions are given, and the study aims to observe natural outcomes while using ultrasound tools to improve fluid management understanding in the ICU setting.
CONDITIONS
Brief Title
Association Between Venous Excess Ultrasound Grading System and Acute Kidney Injury in the ICU Population
Research Team
P
Pieter R Tuinman, PhD
P
P Klompmaker, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here